Últimos Artículos de Diabetes, Obesity and Metabolism
- Trends and disparities in type 1 diabetes–related mortality in the United States, 1999–2023
- High‐intensity interval training induces lactate dehydrogenase B lactylation to inhibit hepatic lipogenesis to alleviate metabolic dysfunction‐associated fatty liver disease
- Real‐world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi‐site retrospective study
- Contribution of genetic and environmental factors to obesity indices and their overlap
- Efsubaglutide alfa in adults with overweight or obesity: Protocol for a seamless, adaptive phase 2b/3 randomized, double‐blind, placebo‐controlled trial (LIGHT 2)
- Obesity‐related distress and obesity burnout: Towards a conceptual framework for disease‐specific emotional burden in obesity
- Sex‐specific changes in GLP‐1RA trends (2019–2024): Impact of FDA approval of semaglutide (Wegovy) for chronic weight management in the United States
- Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions
- Comparison of pharmacodynamics and pharmacokinetics of ultra‐rapid‐acting insulin aspart and rapid‐acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial
- RETRACTION: Effects of GLP‐1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials
- In‐flight glycaemic control using automated insulin delivery systems: A within‐subject comparative pilot study
- Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
- Glucose tolerance and mortality across 24 cancer types and stages: A K‐CURE Nationwide registry study
- Glucose‐dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes—A randomised placebo‐controlled study
- Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial
- Risk of diabetic retinopathy and ophthalmic interventions in patients with diabetes mellitus taking different oral anticoagulants
- Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials
- Challenging the obesity paradox in cognitive function: Weight‐adjusted waist index as an obesity indicator in older adults
- Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia
- Burden of long‐term conditions and management of people with overweight and obesity: Data from the United Kingdom primary care cohort of the IMPACT‐O study